Results 61 to 70 of about 2,807 (168)

The Application of PD‐1 Inhibitors in Immunotherapy for Glioblastoma

open access: yesThe FASEB Journal, Volume 40, Issue 4, 28 February 2026.
The molecular mechanism of PD‐1. When PD‐1 binds to PD‐L1, the ITIM and ITSM domains within PD‐1 are phosphorylated and subsequently recruit SHP‐2. This then dephosphorylates downstream molecules of the TCR, such as PI3K/AKT and ZAP70, reduces the secretion of IFN‐γ, and inhibits the presentation of antigens to T cells via MHC molecules through the ...
Ming‐zhen Dong   +4 more
wiley   +1 more source

Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 2, Page 430-441, February 2026.
Abstract Background Deep brain stimulation (DBS) is an established treatment for Parkinson's disease (PD) in appropriately selected patients. DBS may be underused in certain patient populations, especially women and racialized groups. Barriers and biases to receiving DBS that could account for underuse among these groups are not well studied in Canada.
Fang Ba   +14 more
wiley   +1 more source

Knowledge‐based deep residual U‐Net (DRU) for synthetic CT generation using a single MR volume for frameless radiosurgery

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Purpose To develop a knowledge‐based deep model for sCT generation from a single MR volume in LINAC‐based frameless SRS, enabling the MR‐only workflow without extra CT simulation. Methods A total of 139 patients were included in the study, with 120 used for training and 19 for testing.
Xiwen Shu   +8 more
wiley   +1 more source

RapidArc dynamic versus RapidArc: A multi anatomical‐site dosimetric evaluation

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 1, January 2026.
Abstract Background RapidArc (RA) has advanced VMAT delivery; however, challenges remain in achieving optimal organ‐at‐risk (OAR) sparing in complex cases. RapidArc Dynamic (RAD), a next‐generation Volumetric Modulation Arc Therapy (VMAT) technique, incorporates dynamic collimator rotation, embedded static fields, and a faster optimizer to enhance dose
Aram Rostami   +13 more
wiley   +1 more source

Assessing local control, toxicity with hippocampal avoidance whole-brain radiotherapy with a simultaneous integrated boost for single and limited brain metastases

open access: yesAsian Journal of Medical Sciences
Background: Although whole-brain radiotherapy (WBRT) has been the standard treatment for brain metastases, its cognitive side effects have led to the rise of stereotactic radiosurgery (SRS), which offers better local control with less neurocognitive ...
Poopalan Sivakumar   +4 more
doaj   +1 more source

Sinonasal Sarcomas Management: An International Consensus Statement

open access: yesInternational Forum of Allergy &Rhinology, Volume 16, Issue 1, Page 55-69, January 2026.
ABSTRACT Introduction Sinonasal sarcomas are exceedingly rare entities, constituting less than 7% of head and neck sarcomas. Their complex histology needs specialized treatment, which is often based on multimodal approaches including surgery, radiation therapy, and/or chemotherapy.
Alessandro Vinciguerra   +51 more
wiley   +1 more source

A Systematic Review of the Parkinson's Foundation Hospital Care Recommendations

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 1, Page 29-43, January 2026.
Abstract Background People with Parkinson's disease (PwP) face increased risks of complications and longer hospital stays compared to the general population. Four major factors contribute to increased morbidity and mortality during hospitalization: medication timing errors, administration of harmful medications, restricted mobility, and dysphagia ...
Ariane Veilleux Carpentier   +12 more
wiley   +1 more source

Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma. [PDF]

open access: yesNeurooncol Adv, 2023
Foreman BE   +8 more
europepmc   +1 more source

Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structures. [PDF]

open access: yesHead Neck, 2022
Farris JC   +16 more
europepmc   +1 more source

Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature

open access: yesClinical and Translational Radiation Oncology
Introduction: Although stereotactic ablative radiotherapy (SABR) has advance to standard-of-care for many different indications like lung and liver malignancies, it still remains in its infancy for treating head and neck cancer.
Ciro Franzese, Panagiotis Balermpas
doaj   +1 more source

Home - About - Disclaimer - Privacy